+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID07715747

Phase 1 Study Evaluating Safety, Pharmacokinetics, and Efficacy of TJ037130 in Adults with Advanced Solid Tumors

Led by TJ Biopharma Co., Ltd. · Updated on 2026-10-30

128

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, and optimal biological dose of TJ037130 in adults with advanced or metastatic solid tumors. This phase 1 clinical trial focuses on participants with cancers such as metastatic ovary cancer, gastric cancer, and endometrial carcinoma who have no standard effective therapy available or are ineligible for existing treatments. The study aims to understand how well TJ037130 is tolerated and to identify the best dose for future studies. TJ037130 is given as a drug treatment in varying doses during a dose escalation phase, with dosing levels of 0.75, 2, 5, 10, and 18 mgkg administered once every three weeks. Following dose escalation, the study proceeds to a dose expansion phase where participants receive TJ037130 every three weeks across four cohorts. The treatment is delivered intravenously, and dosing schedules are carefully monitored throughout the trial. Participants will be closely monitored for safety, including the incidence and severity of adverse events up to 90 days after the last dose. Researchers will also study how the drug is processed in the body by measuring pharmacokinetic parameters such as AUCt and Cmax during the same period. The trial requires participants to undergo scheduled visits, laboratory tests, and tumor assessments to evaluate response and safety. The total study duration extends until June 2028, with ongoing follow-up for safety and drug effects.

CONDITIONS

Brief Title

A Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors

Research Team

L

Lina Qin

L

Liting Liu

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here